March 09, 2026
Advance Online

Advance Online
New Oral TYK2 Inhibitor Approved for PsA
Sotyktu® receives second indication from FDA.

Sotyktu® receives second indication from FDA.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.